PharmaCielo Ltd.
PCLO.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 5.83% | 29.47% | 31.79% | -118.84% | 48.09% |
| Total Depreciation and Amortization | -107.69% | -86.22% | -71.77% | 107.28% | 24.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 62.96% | 90.25% | -43.29% | 26.55% | -27.96% |
| Change in Net Operating Assets | -103.48% | -147.39% | 92.85% | 169.17% | -85.33% |
| Cash from Operations | 40.51% | 62.53% | 63.30% | 7.50% | 50.74% |
| Capital Expenditure | -- | -- | -- | 91.52% | 99.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -100.00% | -82.30% | -14.37% | 396.55% |
| Cash from Investing | -100.00% | -100.00% | -81.32% | 9.36% | 118.14% |
| Total Debt Issued | -100.00% | -55.33% | -75.39% | 15.24% | -47.53% |
| Total Debt Repaid | 8.46% | -18.95% | 20.16% | -41.35% | 25.65% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -31.66% | -60.57% | -59.09% | 7.05% | -50.37% |
| Foreign Exchange rate Adjustments | 16.67% | 10.81% | -72.16% | 141.55% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 82.67% | 62.05% | -59.97% | 114.98% | 86.63% |
